Actively Recruiting
Study of Oral 5-Aminolevulinic Acid Hydrochloride Powder for Visualizing Malignant Glioma Tissue During Surgery
Led by Lee's Pharmaceutical Limited · Updated on 2026-10-27
79
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
The trial investigates the use of 5-aminolevulinic acid hydrochloride 5-ALA HCl powder for oral solution to help visualize malignant tissue during surgery in adults suspected or confirmed to have malignant high-grade glioma WHO grade 3 or 4. This phase III, multicenter, open-label, single-arm study aims to evaluate both the visualization capability and safety of 5-ALA HCl in this population. The study focuses on determining how well the fluorescent regions correspond to tumor tissue during surgical resection. Participants will receive an oral dose of 5-ALA HCl powder prepared as a solution 3 hours before anesthesia on the day of surgery, dosed at 20 mgkg with a maximum of 1.5 g per participant. Before taking 5-ALA HCl, participants will receive a single 5-mg intravenous infusion of dexamethasone. During surgery, blue-light excitation will be used to visualize fluorescent tumor tissue, and tissue specimens will be collected from fluorescent and nonfluorescent regions for central histopathological assessment. A contrast-enhanced cranial MRI will be conducted 24 to 72 hours after surgery to assess residual tumor. Throughout the study, participants will be protected from light exposure for 48 hours after the study drug. Safety will be monitored through adverse event reporting, physical exams, vital signs, laboratory tests, ECGs, and neurological assessments using the Karnofsky Performance Status and NIH Stroke Scale. The study will measure the proportion of tumor cells in fluorescent tissue specimens as the primary outcome, with secondary outcomes including postoperative MRI findings and histopathological results from various tissue regions. Safety follow-up extends through day 14 after dosing, with all adverse events recorded during this period.
CONDITIONS
Brief Title
5-Aminolevulinic Acid for Photodynamic Diagnosis of Malignant Glioma
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here